Medical Condition News

RSS

HIV epidemic in MSM could be helped by better interaction with their health system

The second paper in The Lancet Series on HIV in MSM focuses on clinical care, and says that optimum clinical care for sexual and gender minorities is a fundamental human right. “MSM deserve to be treated with respect, and health-care providers need to interact with them in ways that promote disclosure of actionable health information,” say the authors, led by Dr Ken Mayer, Fenway Health, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA, USA.

20 Jul 2012

Treating complex spinal pathologies: an interview with Eric Major

In the approximate $8 billion global spine market, the most specialized and demanding $1 billion complex spine segment includes deformity, trauma, and tumor pathologies.

20 Jul 2012

Short-term infection with intestinal worms may provide long-term protection against TID

Short-term infection with intestinal worms may provide long-term protection against type I diabetes (TID), suggests a study conducted by William Gause, PhD, and colleagues at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School.

20 Jul 2012

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

Life Technologies Corporation today announced it has signed a collaborative partnership with the Structural Genomics Consortium (SGC), and several groups of leading expert scientists in antibody technology at the Universities of Chicago and Toronto, to generate a first-ever master set of quality epigenetic recombinant antibodies for use in disease-related research.

20 Jul 2012

Studies report on therapeutic efficacy of stem cell transplantation in animal models of ALS, SCI

Two studies published in a recent issue of Cell Medicine report on the therapeutic efficacy of stem cell transplantation in animal models of amyotrophic lateral sclerosis (ALS) and spinal cord injury (SCI).

20 Jul 2012

New blood sugar monitor: An interview with Sherita Hill Golden

Type 1 diabetes is a disorder in which the body makes proteins (antibodies) against the cells in the pancreas that produce insulin, destroying those cells. As a result, individuals are unable to secrete insulin to normalize blood sugar and hyperglycemia results.

20 Jul 2012

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Bristol-Myers Squibb Company today reported the result of the phase III BRISK-FL clinical trial of the investigational agent brivanib versus sorafenib as first-line treatment in patients with advanced hepatocellular carcinoma.

20 Jul 2012

Study demonstrates how nerve stimulation paired with specific experiences can reorganize the brain

UT Dallas researchers recently demonstrated how nerve stimulation paired with specific experiences, such as movements or sounds, can reorganize the brain. This technology could lead to new treatments for stroke, tinnitus, autism and other disorders.

20 Jul 2012

Researchers identify six genes with driving mutations in melanoma

It's been a burning question in melanoma research: Tumor cells are full of ultraviolet (UV)-induced genetic damage caused by sunlight exposure, but which mutations drive this cancer? None have been conclusively tied to melanoma. The sheer abundance of these passenger mutations has obscured the search for genetic driver mutations that actually matter in melanoma development and progression.

20 Jul 2012

Baptist Cardiac & Vascular Institute offers new TAVR procedure for patients with aortic stenosis

People who are high-risk for heart valve surgery could have their damaged aortic valve replaced without traditional surgery with a new FDA-approved procedure performed at Baptist Cardiac & Vascular Institute at Baptist Hospital of Miami.

20 Jul 2012

CPAP effectively reduces symptoms and improves QOL in sleepy patients with milder OSA

Continuous positive airway pressure (CPAP), well established as an effective treatment for severe obstructive sleep apnea (OSA), is also effective in patients with mild and moderately severe OSA and daytime sleepiness, according to a new study.

20 Jul 2012

Study helps explain why leukemia occurs more frequently as people age

Hundreds of mutations exist in leukemia cells at the time of diagnosis, but nearly all occur randomly as a part of normal aging and are not related to cancer, new research shows.

20 Jul 2012

Scientists to create new drugs with bone formation stimulating activities

A Simon Fraser University researcher is leading a team of scientists working to create new drugs to stimulate bone regeneration - research that will be furthered by a $2.5 million grant from the Canadian Institutes of Health Research (CIHR).

20 Jul 2012

Vitamin D may modify damaging effects of smoking on lung function

Vitamin D deficiency is associated with worse lung function and more rapid decline in lung function over time in smokers, suggesting that vitamin D may have a protective effect against the effects of smoking on lung function, according to a new study from researchers in Boston.

20 Jul 2012

Nuvo Research receives first three Pliaglis marketing licenses from E.U. countries

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain today announced that Galderma S.A. (Galderma), a global company dedicated to dermatology has received its first three Pliaglis marketing licenses from E.U. countries.

20 Jul 2012

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

Conatus Pharmaceuticals Inc. and the University of Alberta announced today the treatment of the first patient in an investigator-initiated islet cell transplant Phase I/II trial of emricasan (IDN-6556), a pan-caspase inhibitor.

20 Jul 2012

GUMC, MedStar GUH launch Huntington Disease Care, Education and Research Center

Georgetown University Medical Center in collaboration with MedStar Georgetown University Hospital announce the launch of the Huntington Disease Care, Education and Research Center.

20 Jul 2012

Epithilone D effective in preventing Alzheimer's in animal models

While clinical trial results are being released regarding drugs intended to decrease amyloid production - thought to contribute to decline in Alzheimer's disease - clinical trials of drugs targeting other disease proteins, such as tau, are in their initial phases.

20 Jul 2012

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

BioAlliance Pharma SA, an innovative Company dedicated to the development of orphan oncology products and to supportive care products, announces it has signed a binding term sheet with Vestiq for the commercialization rights in the United States of Oravig (known as Loramyc in Europe) for the treatment of oropharyngeal candidiasis in adults.

20 Jul 2012

Covidien receives Brazilian approval for Solitaire FR Revascularization Device

Covidien, a leading global provider of healthcare products, today announced that the Solitaire FR Revascularization Device has been approved by Brazil's National Health Surveillance Agency. The Solitaire FR device is used to restore blood flow to the brain in patients suffering acute ischemic stroke.

20 Jul 2012

Medical Condition News

HIV epidemic in MSM could be helped by better interaction with their health system

Treating complex spinal pathologies: an interview with Eric Major

Short-term infection with intestinal worms may provide long-term protection against TID

SGC, Life Technologies to generate first-ever master set of epigenetic recombinant antibodies

Studies report on therapeutic efficacy of stem cell transplantation in animal models of ALS, SCI

New blood sugar monitor: An interview with Sherita Hill Golden

Bristol-Myers Squibb reports results from brivanib plus sorafenib phase III trial on HCC

Study demonstrates how nerve stimulation paired with specific experiences can reorganize the brain

Researchers identify six genes with driving mutations in melanoma

Baptist Cardiac & Vascular Institute offers new TAVR procedure for patients with aortic stenosis

CPAP effectively reduces symptoms and improves QOL in sleepy patients with milder OSA

Study helps explain why leukemia occurs more frequently as people age

Scientists to create new drugs with bone formation stimulating activities

Vitamin D may modify damaging effects of smoking on lung function

Nuvo Research receives first three Pliaglis marketing licenses from E.U. countries

Conatus, University of Alberta initiate islet cell transplant Phase I/II trial of emricasan for diabetes

GUMC, MedStar GUH launch Huntington Disease Care, Education and Research Center

Epithilone D effective in preventing Alzheimer's in animal models

BioAlliance Pharma, Vestiq enter license agreement for Oravig to treat oropharyngeal candidiasis

Covidien receives Brazilian approval for Solitaire FR Revascularization Device

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News